A retrospetive study investigating impact of pretransplantation Mogamulizumab treatment on clinical outcomes after allogeneic hematopoietic stem-cell transplantation in patients with aggressive Adult T-Cell Leukemia/Lymphoma.
Phase of Trial: Phase IV
Latest Information Update: 24 Oct 2016
At a glance
- Drugs Mogamulizumab (Primary)
- Indications Adult T-cell leukaemia-lymphoma
- Focus Adverse reactions; Therapeutic Use
- 24 Oct 2016 New trial record